Send me a link:

*Text messaging rates may apply.

 Dow Up 0.39% Nasdaq Up 0.77%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
4.94 Up 0.01(0.20%) 1:33PM EDT - Nasdaq Real Time Price
Prev Close:4.93
Open:4.96
Bid:4.95 x 500
Ask:4.96 x 1300
1y Target Est:9.50
Beta:1.7
Next Earnings Date:N/A
Day's Range:4.91 - 5.13
52wk Range:3.10 - 7.45
Volume:710,775
Avg Vol (3m):1,387,110
Market Cap:343.60M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 0.20%343.60M
DNDNDown 0.93%328.83M
NKTRUp 1.46%1.41B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):46.02
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.20
Quarterly EPS Est (Jun-14) :-0.14
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback